NDC 0023-8842

ALOCRIL

Nedocromil Sodium

ALOCRIL is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Nedocromil Sodium.

Product ID0023-8842_0aeb87da-f1d5-4a28-ad87-80fb3c31b3ea
NDC0023-8842
Product TypeHuman Prescription Drug
Proprietary NameALOCRIL
Generic NameNedocromil Sodium
Dosage FormSolution/ Drops
Route of AdministrationOPHTHALMIC
Marketing Start Date2000-02-03
Marketing CategoryNDA / NDA
Application NumberNDA021009
Labeler NameAllergan, Inc.
Substance NameNEDOCROMIL SODIUM
Active Ingredient Strength20 mg/mL
Pharm ClassesDecreased Histamine Release [PE], Mast Cell Stabilizer [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0023-8842-05

1 BOTTLE, DROPPER in 1 CARTON (0023-8842-05) > 5 mL in 1 BOTTLE, DROPPER
Marketing Start Date2000-02-03
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0023-8842-05 [00023884205]

ALOCRIL SOLUTION/ DROPS
Marketing CategoryNDA
Application NumberNDA021009
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2000-02-03

Drug Details

Active Ingredients

IngredientStrength
NEDOCROMIL SODIUM20 mg/mL

OpenFDA Data

SPL SET ID:2fe8d7ad-2158-4169-94b0-719ad20242b7
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 897294
  • 897292
  • UPC Code
  • 0300238842053
  • Pharmacological Class

    • Decreased Histamine Release [PE]
    • Mast Cell Stabilizer [EPC]
    • Decreased Histamine Release [PE]
    • Mast Cell Stabilizer [EPC]

    NDC Crossover Matching brand name "ALOCRIL" or generic name "Nedocromil Sodium"

    NDCBrand NameGeneric Name
    0023-8842ALOCRILnedocromil sodium
    17478-066Nedocromil SodiumNedocromil Sodium

    Trademark Results [ALOCRIL]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ALOCRIL
    ALOCRIL
    75802644 2458487 Live/Registered
    ALLERGAN, INC.
    1999-09-17

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.